JPRN-UMIN000010016已完成未知
The effects of DPP-4 inhibitor on vascular endothelial function in patients with type 2 diabetes mellitus - The effects of DPP-4 inhibitor on vascular endothelial function in patients with type 2 diabetes mellitus
ippon Medical School Department of Medicine Division of Cardiology0 个研究点目标入组 40 人开始时间: 2013年2月12日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Type I diabetes mellitus 2) Patients receiving insulin therapy 3) Severe renal dysfunction requiring hemodialysis or peritoneal dialysis 4) Severe hepatopathy/nephropathy or heart disease that may affect the evaluation of drug safety 5) Patients who are deemed to be inappropriate by the investigator or sub-investigators
研究者
相似试验
已完成
不适用
Effect of a DPP-4 inhibitor on vascular endothelial function in type 2 diabetic patientsType 2 diabetic patientsJPRN-UMIN000004746ippon Medical School Department of Medicine Division of Cardiology, Hepatology,Geriatrics and Integrated Medicine50
已完成
不适用
The effects of a DPP4 inhibitor on endothelial function in diabetic patients with coronary artery diseaseJPRN-UMIN000008806Department of Cardiovascular Medicine, Faculty of Life Sciences, Kumamoto University30
已完成
不适用
Effect of DPP-4(dipeptidyl peptidase-4) inhibitor for coronary plaque in diabetes patients.JPRN-UMIN000007255Center for Cardiovascular Interventions,Chiba University Hospital128
已完成
不适用
Effects of dipeptidyl peptidase-4 (DPP-4) inhibitor, alogliptin, on coronary atherosclerosis in patients with type 2 diabetes mellitusPatients with type 2 diabetes mellitus who were suspected as having ischemic heart diseaseJPRN-UMIN000015381Kanagawa PTCA Conference50
尚未招募
不适用
The inhibitory effects of the DPP-4 inhibitor for progression of diabetic nephropathy, in the patients with type 2 diabetes in Japan.The CKD patients with type 2 diabetesJPRN-UMIN000011101Saitama Medical Center, Saitama Medical University50